Stay updated on Telisotuzumab vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Expanded the Study Details by adding a comprehensive list of enrollment sites across the United States and multiple countries and removed the HHS Vulnerability Disclosure section.
    Difference
    4%
    Check dated 2025-12-19T12:15:06.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision label in the page footer updated to v3.3.2; Revision v3.3.1 was removed.
    Difference
    0.0%
    Check dated 2025-11-28T01:38:11.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.1; the visible study content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-20T23:07:37.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    Added a new site in São Paulo, Brazil (01308-050) at Hospital Sirio Libanes (ID 261827) and removed the previous listing with the same ID. The government funding status notice was deleted from the page.
    Difference
    0.3%
    Check dated 2025-11-13T17:04:54.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Added new locations such as Humanitas Istituto Clinico Catanese in Misterbianco (Italy) and Instituto de Oncología Angel H. Roffo in Buenos Aires, Argentina, and removed Memphis VA Medical Center and Osaka location entries; total locations increased from 307 to 309.
    Difference
    0.2%
    Check dated 2025-11-06T13:45:53.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    No changes to core study details (title, eligibility criteria, primary outcomes, enrollment, or locations) were observed; only minor layout and user interface adjustments were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-10-30T11:28:40.000Z thumbnail image

Stay in the know with updates to Telisotuzumab vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telisotuzumab vs Docetaxel in NSCLC Clinical Trial page.